Home › ASCO15: AngioChem Presents ANG1005 Data On Breast Cancer Patients...
 

Keywords :   


ASCO15: AngioChem Presents ANG1005 Data On Breast Cancer Patients...

2015-06-02 00:37:09| Logistics - Topix.net

Angiochem, a clinical stage biotechnology company creating and developing drugs that cross the blood-brain barrier, today announced that results from an ongoing multi-center Phase II study were presented on Saturday, May 30, 2015 at the 2015 American Society for Clinical Oncology annual meeting being held in Chicago. The trial was designed to evaluate the activity of ANG1005, a novel taxane-peptide conjugate able to cross the blood brain barrier and enter cancer cells by targeting the LRP-1 receptor, in metastatic breast cancer patients.

Tags: data cancer presents patients

Category:Transportation and Logistics

Latest from this category

All news
25.09Summary for Tropical Storm Helene (AT4/AL092024)
25.09Tropical Storm Helene Public Advisory Number 8A
25.09Atlantic Tropical Weather Outlook
25.09Eastern North Pacific Tropical Weather Outlook
25.09Eastern North Pacific Tropical Weather Outlook
25.09Tropical Storm Helene Potential Storm Surge Flooding Map
25.09Tropical Storm Helene Probabilistic Storm Surge Graphics
25.09Tropical Storm Helene Forecast Discussion Number 8
Transportation and Logistics »
25.09Companies raided over tax relief fraud allegations
25.09Banks must refund fraud up to 85,000 in five days
25.09Proposed Federal Law Targets Plastic Barrage; Follows Similar National Efforts
25.09Stericycle Recognized by TIME and Statista as One of America's Best Midsize Companies
25.09Wild Republic Partners with SSA Group to Launch Innovative Zero Waste Box Program for Plush Recycling
25.09NOVUS partnering with biotech company to develop new feed additives
25.09GARDCO Introduces New Certified Gel Timers
25.09Tropical Storm Helene Public Advisory Number 8A
More »